Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding
autor
vastutusandmed
T.Päll, A.Gad, L.Kasak, M.Drews, S.Strömblad, P.Kogerman
allikas
ajakirja aastakäik number kuu
23
ilmumisaasta
leheküljed
47, p. 7874-7881
keel
inglise
Päll, T., Gad, A., Kasak, L., Drews, M., Strömblad, S., Kogerman, P. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding // Oncogene (2004) 23, 47, p. 7874-7881.